Given the role for SIRT6 in lymphocyte and dendritic cell activation [3, 9], we evaluated the effect of the SIRT6 inhibitor, compound 1 in a Th1/Th17-driven model of autoimmune disorder of the central nervous system (CNS), such as EAE. Here, SIRT6 is linked to autoimmune disorder of central nervous system.